From Thought Leadership to Stock Value: Can Marketing Fuel Growth?

We all know marketing as a major tool to drive leads and sales, but can it also help to grow the company's fundraising potential or drive stock value of a publicly traded company?

The recent MedTech Marketing at Scale experience with Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) shows that with the right approach - this is an achievable target!

Increasing share price and trade volume are key success factors for any public company.

Together with Scinai CEO Amir Reichman and the leadership team, we crafted a marketing strategy with two main pillars:

1. Showcasing the full value of Scinai’s innovative product pipeline.
2. Reaching the right target audience and sparking interest in Scinai Immunotherapeutics Ltd.

Our Approach:

1. Communicating innovation

Recently, Scinai achieved significant milestones in its R&D pipeline of VHH antibodies, developing an innovative localized intralesional injections treatment solution for plaque Psoriasis. While each milestone was shared through individual press releases, we chose to provide deeper insights into the journey through an online expert panel featuring leading dermatology and immunology specialists alongside Scinai Executives. This panel, held in conjunction with Psoriasis Awareness Month, offered a broader perspective on the unmet needs in the market and introduced Scinai’s innovative solution for treating mild to moderate plaque psoriasis.

The session was meticulously planned, resulting in a dynamic and engaging discussion

View the webinar recording

2. Targeted promotion campaign: Reaching the right people. With the right message

We identified the most relevant target audience of key stakeholders and created a multi-channel promotion campaign that included PR, social media and email outreach.

This strategy created a buzz and atrracted attention to the event. We further amplified the impact by personalized outreach to top relevant prospects.

The results?

With over 200 registrants, including analysts, investors, and potential partners, the Scinai Online Expert Panel was a great success!

On the same day, we saw an overwhelmingly positive market response, with a 33% increase in stock price and a 16-fold surge in trading volume.

Additionally, after publishing the webinar on YouTube, we received enthusiastic feedback from psoriasis sufferers, who expressed excitement and hope for this potential solution to address their unmet needs.

Overall this was a highly impactful event and a great example how thought leadership can lead the company to business success.

Many thanks to the Scinai team for their trust and collaboration and a huge shout out to the all star The MedTech Marketing team who worked relentlessly on this project - Ze'ev Gurman , Melinda (Gedman) Matkowsky, Moran Yadid

I highy recommend innovative healthcare technologies companies taking a proactive approach and finding their growth catalyst. Melinda (Gedman) Matkowsky

I hope that you found this case study valuable and useful. Welcome to share your thoughts and insights in the comments.